Certified by Founder Lodge
NRG Therapeutics
United Kingdom - Stevenage, Hertfordshire
START UP
1 Disclosed Funding Rounds $67,835,242
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mitochondrial therapeutics for the treatment of neurodegenerative diseases
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 09 ,2025 | Series B | $67,835,242 |
Omega Funds
British Business Bank
Brandon Capital
Criteria Bio Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
StretchSense | $2,300,000 | (Dec 23, 2025)
Ciphero | $2,500,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
